Alcon Inc. (SWX:ALC)

Market Cap	30.78B
Revenue (ttm)	8.12B +4.3%
Net Income (ttm)	834.86M -9.8%
EPS (ttm)	1.67 -10.2%
Shares Out	491.20M
PE Ratio	37.42
Forward PE	24.53
Dividend	0.28 (0.44%)
Ex-Dividend Date	May 13, 2025

Volume	116,627
Average Volume	1,001,611
Open	62.66
Previous Close	62.66
Day's Range	62.32 - 62.76
52-Week Range	57.68 - 87.00
Beta	0.69
RSI	46.13
Earnings Date	Feb 24, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,000
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: ALC

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD